Manchester Capital Management’s Idexx Laboratories IDXX Stock Holding History

Manchester Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64.6K	Buy	115 +2	+2%	+$1.28K	0.01%	448
2025 Q4	$76.4K	Buy	113 +8	+8%	+$5.45K	0.01%	417
2025 Q3	$67.1K	Sell	105 -27	-20%	-$16.4K	0.01%	502
2025 Q2	$70.8K	Sell	132 -110	-45%	-$52.6K	0.01%	511
2025 Q1	$102K	Buy	242 +42	+21%	+$18.2K	0.01%	430
2024 Q4	$82.7K	Sell	200 -6	-3%	-$2.63K	0.01%	454
2024 Q3	$104K	Sell	206 -14	-6%	-$6.8K	0.01%	426
2024 Q2	$107K	Buy	220 +27	+14%	+$13.6K	0.01%	410
2024 Q1	$104K	Buy	193 +5	+3%	+$2.73K	0.01%	402
2023 Q4	$104K	Buy	188 +20	+12%	+$9.39K	0.01%	356
2023 Q3	$73.5K	Sell	168 -81	-33%	-$40.4K	0.01%	377
2023 Q2	$125K	Sell	249 -161	-39%	-$77.2K	0.02%	323
2023 Q1	$205K	Buy	410 +388	+1,764%	+$186K	0.03%	288
2022 Q4	$8.97K	Buy	+22	New	+$8.54K	﹤0.01%	473
2021 Q4	–	Sell	-510	Closed	-$317K	–	1054
2021 Q3	$317K	Hold	510	–	–	0.04%	221
2021 Q2	$322K	Sell	510 -14	-3%	-$7.73K	0.04%	222
2021 Q1	$256K	Buy	524 +4	+0.8%	+$2K	0.04%	237
2020 Q4	$260K	Buy	520 +6	+1%	+$2.69K	0.04%	217
2020 Q3	$202K	Buy	514 +4	+0.8%	+$1.48K	0.03%	217
2020 Q2	$168K	Hold	510	–	–	0.02%	252
2020 Q1	$124K	Buy	510 +60	+13%	+$15.7K	0.02%	267
2019 Q4	$118K	Hold	450	–	–	0.01%	288
2019 Q3	$122K	Hold	450	–	–	0.01%	275
2019 Q2	$124K	Hold	450	–	–	0.02%	277
2019 Q1	$101K	Buy	450 +166	+58%	+$34.3K	0.01%	304
2018 Q4	$62K	Hold	284	–	–	0.01%	333
2018 Q3	$71K	Hold	284	–	–	0.01%	323
2018 Q2	$62K	Buy	284 +56	+25%	+$11.5K	0.01%	340
2018 Q1	$44K	Hold	228	–	–	0.01%	364
2017 Q4	$36K	Buy	+228	New	+$35.9K	0.01%	377
2015 Q3	–	Sell	-8,000	Closed	-$513K	–	637
2015 Q2	$513K	Hold	8,000	–	–	0.08%	111
2015 Q1	$617K	Hold	8,000	–	–	0.1%	92
2014 Q4	$593K	Hold	8,000	–	–	0.07%	121
2014 Q3	$471K	Hold	8,000	–	–	0.06%	146
2014 Q2	$534K	Hold	8,000	–	–	0.07%	142
2014 Q1	$486K	Hold	8,000	–	–	0.08%	146
2013 Q4	$425K	Hold	8,000	–	–	0.07%	170
2013 Q3	$399K	Hold	8,000	–	–	0.07%	178
2013 Q2	$359K	Buy	+8,000	New	+$350K	0.07%	178

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manchester Capital Management's IDXX Position: Q1 2026 in Review

Manchester Capital Management increased its Idexx Laboratories (IDXX) stake by 1.8% in Q1 2026, buying an estimated $1.28K and bringing the position to 115 shares worth $64.6K. The position accounts for 0.01% of the portfolio, ranked #448.

Manchester Capital Management first reported a position in IDXX in Q2 2013 and has held it in 39 quarters since. The position peaked at $617K in Q1 2015. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Manchester Capital Management held 115 shares of Idexx Laboratories worth $64.6K as of Q1 2026.
Manchester Capital Management bought 2 Idexx Laboratories shares in Q1 2026, an estimated $1.28K.
Idexx Laboratories made up 0.01% of Manchester Capital Management's portfolio in Q1 2026, its #448 holding.
Manchester Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 39 quarters since.
Manchester Capital Management's Idexx Laboratories position peaked at $617K in Q1 2015.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.